EMBIO Diagnostics has become the first Cypriot company to secure funding through the EIC Pre-Accelerator – Widening, part of the European Union’s Horizon Europe programme. The funding marks a significant step for the company and contributes to the development of Cyprus’ innovation ecosystem.
The funding will support the development of RapidX – Real-time Access to Predictive Intelligent Diagnostics – eXpert sensing, a breakthrough AI-enabled platform designed to transform real-time industrial diagnostics.
RapidX is a breakthrough deep-tech project developed by EMBIO Diagnostics to transform how porous industrial materials are tested, monitored and evaluated.
Today, many industries still rely on centralized laboratory testing methods that can take 24 to 72 hours, require specialized equipment, involve chemical reagents and create additional cost and waste. RapidX aims to address this challenge by enabling fast, on-site and reagent-free diagnostics for industrial environments.
The project will focus on the development and validation of a portable, AI-enabled electrochemical diagnostic platform capable of rapidly assessing the performance of materials such as cementitious products, construction materials and granular activated carbon used in water-treatment applications.
Building on EMBIO’s existing B.EL.D™ technology architecture, RapidX will combine electrochemical sensing, AI-enabled analytics and cloud-connected diagnostics to generate actionable insights on material performance, porosity and lifecycle behaviour.
Through this project, EMBIO Diagnostics will lead the technological development, validation, intellectual property management, commercialisation strategy and investor-readiness pathway for RapidX.
For the cement and construction industries, RapidX has the potential to support faster quality control, improved process optimisation and reduced energy use. In water-treatment applications, it can support better monitoring of filtration materials, predictive maintenance and more sustainable asset management.
